{"product_id":"hemostats-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Hemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eHemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nThe global hemostats market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.97% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eHemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used in adjunct to surgical procedures to manage bleeding. Hemostatic agents offer various benefits, including decreased wound healing and operative time, better management of anticoagulated patients, and reduction in the patient recovery period. A wide range of surgical hemostatic agents is available in the market that vary widely in their composition, cost, immunogenicity, mechanism of action, application and adherence.\u003c\/p\u003e\n\n\u003cp\u003eOn account of the significant rise in the prevalence of chronic disorders, cesarean deliveries, fatal injuries and major organ surgeries, there has been an increasing demand for hemostats. These agents help prevent blood loss during surgical procedures, particularly for nonanatomic and sensitive structures, and among patients with hemostatic abnormalities. Besides this, their use helps in lowering the cost of the procedure, which has led to their rapid adoption among healthcare providers. Moreover, with technological advancements, leading manufacturers have developed absorbable adjunctive hemostats that help professionals to control disruptive bleeding more efficiently as compared to traditional methods. Additionally, they are utilizing nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding. Market players have also introduced advanced laparoscopic hemostats designed to enhance the quality of surgical operations and allow for less invasive procedures. Along with these developments, improvements in healthcare facilities and extensive research and development (R\u0026amp;D) activities to launch new products, are providing a positive impact on the industry.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global hemostats market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and formulation.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eThrombin Based\u003cbr\u003e\nCombination Based\u003cbr\u003e\nOxidized Regenerated Cellulose Based\u003cbr\u003e\nGelatin Based\u003cbr\u003e\nCollagen Based\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eOrthopedic Surgery\u003cbr\u003e\nGeneral Surgery\u003cbr\u003e\nNeurological Surgery\u003cbr\u003e\nCardiovascular Surgery\u003cbr\u003e\nReconstructive Surgery\u003cbr\u003e\nGynecological Surgery\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Formulation:\u003c\/p\u003e\n\n\u003cp\u003eMatrix and Gel Hemostats\u003cbr\u003e\nSheet and Pad Hemostats\u003cbr\u003e\nSponge Hemostats\u003cbr\u003e\nPowder Hemostats\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe report has also analysed the competitive landscape of the market with some of the key players being Arch Therapeutics Inc., Baxter International Inc., B. Braun Melsungen Aktiengesell, C. R. Bard Inc., GELITA MEDICAL GmbH, Integra LifeSciences Corporation, Johnson \u0026amp; Johnson, Pfizer Inc., Stryker Corporation, Teleflex Incorporated and Z-Medica LLC.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eHow has the global hemostats market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global hemostats market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the application?\u003cbr\u003e\nWhat is the breakup of the market based on the formulation?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global hemostats market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 140 Pages \/ MCW16245673","offer_id":47662745944370,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/hemostats-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}